KRAS inhibitor-4
| Code | Size | Price |
|---|
| TAR-T11772-5mg | 5mg | £1,167.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
KRAS inhibitor-4 developed as anticancer agents, is a potent KRAS inhibitor.
CAS:
2374152-69-7
Formula:
C30H39ClN8O
Molecular Weight:
563.15
Purity:
0.98
SMILES:
C[C@@H]1Cc2c(C[C@H]1c1c(Cl)c(C)cc3[nH]ncc13)nc(nc2N1CCN([C@H](C)C1)C(=O)C=C)N1CC(C1)N(C)C
References
1. CHEN, Ping, et al. TETRAHYDROQUINAZOLINE DERIVATIVES USEFUL AS ANTICANCER AGENTS. WO2019155399.